1714.Tw
The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
Business. The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
The company maintains a relatively strong liquidity position, with a current ratio of 3.24, indicating that it has sufficient short-term assets to cover its short-term liabilities. However, its liquidity risk is assessed as medium, likely due to the negative net cash position after subtracting total debt. The price-to-book ratio of 0.77 suggests that the company is trading at a discount relative to its book value, which may reflect market concerns about its asset quality or future earnings potential.
Profitability metrics show that the company is underperforming relative to industry norms. The return on equity (ROE) of 4.02% is below the typical range for the Commodity Chemicals industry, and the return on assets (ROA) of 1.96% is similarly weak. These figures suggest that the company is not effectively utilizing its equity or assets to generate returns, which could be a concern for investors.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification reported. This lack of diversification increases the company's exposure to regional economic downturns or supply chain disruptions. The absence of detailed segment or geographic breakdowns in the available data limits the ability to assess the specific risks associated with its operations.
Looking ahead, the company's growth trajectory appears modest. Based on the available financial data, there is no indication of significant revenue growth in the current or next fiscal year. The company's capital expenditures are relatively low, which may suggest a conservative approach to expansion or a focus on maintaining existing operations rather than investing in new projects.
The company's risk profile is characterized by a low dilution potential, as the number of diluted shares is the same as the basic shares outstanding. However, the risk assessment highlights a key flag: the company has a negative net cash position after subtracting total debt, which could pose a liquidity risk if cash flow from operations does not improve. Additionally, the debt-to-equity ratio of 0.25 indicates a relatively low level of leverage, which is generally favorable but may also suggest a conservative capital structure that could limit growth opportunities.
There are no recent events or filings disclosed in the available data that would significantly impact the company's operations or financial position. The absence of recent earnings call transcripts or regulatory filings means that there is limited insight into management's strategic direction or response to industry challenges.
- The company has a strong current ratio but faces liquidity risk due to a negative net cash position after debt.
- ROE and ROA are below industry norms, indicating weak profitability and asset utilization.
- The company lacks geographic and segment diversification, increasing exposure to regional risks.
- Growth appears limited, with no significant revenue or capital expenditure increases in recent periods.
- The company has a low dilution risk but may be under-leveraged, potentially limiting growth opportunities.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- 1714.TW Market data — financials · 2026-05-26